Related Experiment Video
Updated: Dec 29, 2025

Treatment of Osteochondral Defects in the Rabbit's Knee Joint by Implantation of Allogeneic Mesenchymal Stem Cells in Fibrin Clots
Published on: May 21, 2013
Meniscal Allograft Transplantation: Indications, Techniques, Outcomes
1Midwest Orthopaedics at Rush University Medical Center, Chicago, IL; Department of Orthopaedic Surgery, Shamir Medical Center and Tel Aviv University, Tel Aviv, Israel.
Meniscal allograft transplantation (MAT) is a viable surgical option for younger patients with meniscal deficiency, offering significant patient-reported outcome improvements. Despite a notable reoperation rate, MAT survival rates remain promising for select individuals.
Area of Science:
- Orthopedic surgery
- Sports medicine
- Regenerative medicine
Background:
- Meniscal allograft transplantation (MAT) is an established surgical treatment for symptomatic meniscal deficiency in select patients, typically under 50 years old.
- It can be combined with anterior cruciate ligament reconstruction or articular cartilage repair in the same knee compartment.
- Contraindications include severe osteoarthritis, uncorrectable malalignment, instability, irreparable chondral damage, infection, or inflammatory arthropathy.
Purpose of the Study:
- To review the current indications, contraindications, graft preservation methods, surgical techniques, and outcomes of meniscal allograft transplantation (MAT).
- To provide an overview of the survival rates, failure times, patient-reported outcomes, and reoperation rates associated with MAT.
- To highlight the limitations of existing studies and suggest future directions for improving MAT outcomes.
Main Methods:
- Review of current literature on meniscal allograft transplantation (MAT).
- Analysis of graft preservation techniques, surgical approaches (open vs. arthroscopic), and fixation methods (soft-tissue, bone-plug, bone-bridge, inside-out, all-inside).
- Evaluation of reported survival rates, time to failure, patient-reported outcomes, and reoperation rates, considering study quality and patient heterogeneity.
Main Results:
- MAT survival rates are estimated at 73.5% at 10 years and 60.3% at 15 years, with mean failure times around 8.2 years (medial) and 7.6 years (lateral).
- Significant improvements in patient-reported outcomes are observed, with 90% of patients willing to undergo the procedure again.
- Reoperation rates are approximately 32%, with meniscal allograft tear being the most common complication.
Conclusions:
- Meniscal allograft transplantation (MAT) is an acceptable treatment for select young patients with meniscal deficiency, offering good functional recovery and high patient satisfaction.
- Fresh-frozen allografts are preferred, and concomitant knee conditions should be addressed for optimal results.
- Further research is needed to overcome study limitations and enhance MAT outcomes through improved patient selection, graft preparation, and surgical techniques.
More Related Videos
08:58Matrix-assisted Autologous Chondrocyte Transplantation for Remodeling and Repair of Chondral Defects in a Rabbit Model
Published on: May 21, 2013
08:30Surgical Retrieval, Isolation and In vitro Expansion of Human Anterior Cruciate Ligament-derived Cells for Tissue Engineering Applications
Published on: April 30, 2014